Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical OncologyLandscape of KRAS(G12C), Associated Genomic Alterations, and Interrelation w. Immuno-Oncology Biomarkers in KRAS-Mutated Cancers

The KRASG12C mutation was more prevalent in females and older patients and appeared to be associated with smoking status. KRASG12C tumors exhibited a distinct co-mutation profile and were associated with tumor mutational burden-high status.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form